|
|
 | | | |
- close
- close
- close
- close
| |||||||||
This excerpt taken from the ELN 20-F filed Feb 28, 2008. Oral
Controlled-Release (OCR) Technologies
OCR technologies provide significant benefits in developing
innovative products that provide meaningful clinical benefits to
patients. EDT has developed a range of OCR technologies, which
it applies to help overcome many of the technical difficulties
that have been encountered in developing oral controlled-release
products. Oral controlled-release products are often difficult
to formulate, develop and manufacture. As a result, significant
experience, expertise and know-how are required to successfully
develop such products.
EDT’s OCR technologies are focused on using advanced drug
delivery technology and its manufacturing expertise to
formulate, develop and manufacture controlled-release, oral
dosage form pharmaceutical products that improve the release
characteristics and efficacy of active drug agents, and also
provide improved patient convenience and compliance. The drug
delivery technologies employed, coupled with its manufacturing
expertise, enable EDT to cost-effectively develop value-added
products and to enhance product positioning.
EDT’s suite of OCR technologies has been incorporated into
many commercialized products. EDT’s OCR technology platform
allows a range of release profiles and dosage forms to be
engineered. Customized release profiles for oral dosage forms
such as extended release, delayed release and pulsatile release
have all been successfully developed and commercialized.
|
| |||||||
